These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17355962)

  • 1. RUNX1-RUNX1 homodimerization modulates RUNX1 activity and function.
    Li D; Sinha KK; Hay MA; Rinaldi CR; Saunthararajah Y; Nucifora G
    J Biol Chem; 2007 May; 282(18):13542-51. PubMed ID: 17355962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
    Harada Y; Harada H
    J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repression of RUNX1 activity by EVI1: a new role of EVI1 in leukemogenesis.
    Senyuk V; Sinha KK; Li D; Rinaldi CR; Yanamandra S; Nucifora G
    Cancer Res; 2007 Jun; 67(12):5658-66. PubMed ID: 17575132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Runx1 regulation of Pu.1 corepressor/coactivator exchange identifies specific molecular targets for leukemia differentiation therapy.
    Gu X; Hu Z; Ebrahem Q; Crabb JS; Mahfouz RZ; Radivoyevitch T; Crabb JW; Saunthararajah Y
    J Biol Chem; 2014 May; 289(21):14881-95. PubMed ID: 24695740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of RUNX1-JAK2 in Human Induced Pluripotent Stem Cell-Derived Hematopoietic Cells Activates the JAK-STAT and MYC Pathways.
    Fortschegger K; Husa AM; Schinnerl D; Nebral K; Strehl S
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Leukemia Inhibitory Factor Receptor Gene Is a Direct Target of RUNX1.
    Qadi AA; Taberlay PC; Phillips JL; Young A; West AC; Brettingham-Moore KH; Dickinson JL; Holloway AF
    J Cell Biochem; 2016 Jan; 117(1):49-58. PubMed ID: 26060100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell exhaustion due to Runx1 deficiency is prevented by Evi5 activation in leukemogenesis.
    Jacob B; Osato M; Yamashita N; Wang CQ; Taniuchi I; Littman DR; Asou N; Ito Y
    Blood; 2010 Feb; 115(8):1610-20. PubMed ID: 20008790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Activated leukemic oncogenes responsible for neoplastic transformation of hematopoietic cells].
    Baskaran D; Spirin PV; Prasolov VS
    Mol Biol (Mosk); 2010; 44(3):418-30. PubMed ID: 20608165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gatekeeper function of the RUNX1 transcription factor in acute leukemia.
    Niebuhr B; Fischer M; Täger M; Cammenga J; Stocking C
    Blood Cells Mol Dis; 2008; 40(2):211-8. PubMed ID: 17920312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for RUNX1 in hematopoiesis and myeloid leukemia.
    Ichikawa M; Yoshimi A; Nakagawa M; Nishimoto N; Watanabe-Okochi N; Kurokawa M
    Int J Hematol; 2013 Jun; 97(6):726-34. PubMed ID: 23613270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal and transforming functions of RUNX1: a perspective.
    Mikhail FM; Sinha KK; Saunthararajah Y; Nucifora G
    J Cell Physiol; 2006 Jun; 207(3):582-93. PubMed ID: 16250015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent transcriptional deregulation of AML1/RUNX1 and GATA factors by the AML1-TRPS1 chimeric gene in t(8;21)(q24;q22) acute myeloid leukemia.
    Asou N; Yanagida M; Huang L; Yamamoto M; Shigesada K; Mitsuya H; Ito Y; Osato M
    Blood; 2007 May; 109(9):4023-7. PubMed ID: 17244685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic stem cells acquire survival advantage by loss of RUNX1 methylation identified in familial leukemia.
    Matsumura T; Nakamura-Ishizu A; Muddineni SSNA; Tan DQ; Wang CQ; Tokunaga K; Tirado-Magallanes R; Sian S; Benoukraf T; Okuda T; Asou N; Matsuoka M; Osato M; Suda T
    Blood; 2020 Oct; 136(17):1919-1932. PubMed ID: 32573733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic Runx1 chromatin boundaries affect gene expression in hematopoietic development.
    Owens DDG; Anselmi G; Oudelaar AM; Downes DJ; Cavallo A; Harman JR; Schwessinger R; Bucakci A; Greder L; de Ornellas S; Jeziorska D; Telenius J; Hughes JR; de Bruijn MFTR
    Nat Commun; 2022 Feb; 13(1):773. PubMed ID: 35140205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the oligomerization domain of ETO interferes with RUNX1/ETO oncogenic activity in t(8;21)-positive leukemic cells.
    Wichmann C; Chen L; Heinrich M; Baus D; Pfitzner E; Zörnig M; Ottmann OG; Grez M
    Cancer Res; 2007 Mar; 67(5):2280-9. PubMed ID: 17332359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ETV6-RUNX1 interacts with a region in SPIB intron 1 to regulate gene expression in pre-B-cell acute lymphoblastic leukemia.
    Xu LS; Francis A; Turkistany S; Shukla D; Wong A; Batista CR; DeKoter RP
    Exp Hematol; 2019 May; 73():50-63.e2. PubMed ID: 30986496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-intrinsic depletion of Aml1-ETO-expressing pre-leukemic hematopoietic stem cells by K-Ras activating mutation.
    Di Genua C; Norfo R; Rodriguez-Meira A; Wen WX; Drissen R; Booth CAG; Povinelli B; Repapi E; Gray N; Carrelha J; Kettyle LM; Jamieson L; Neo WH; Thongjuea S; Nerlov C; Mead AJ
    Haematologica; 2019 Nov; 104(11):2215-2224. PubMed ID: 30975913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proleukemic RUNX1 and CBFbeta mutations in the pathogenesis of acute leukemia.
    Engel ME; Hiebert SW
    Cancer Treat Res; 2010; 145():127-47. PubMed ID: 20306249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular targeting of aberrant transcription factors in leukemia: strategies for RUNX1/ETO.
    Wichmann C; Grez M; Lausen J
    Curr Drug Targets; 2010 Sep; 11(9):1181-91. PubMed ID: 20583973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definitive hematopoiesis requires Runx1 C-terminal-mediated subnuclear targeting and transactivation.
    Dowdy CR; Xie R; Frederick D; Hussain S; Zaidi SK; Vradii D; Javed A; Li X; Jones SN; Lian JB; van Wijnen AJ; Stein JL; Stein GS
    Hum Mol Genet; 2010 Mar; 19(6):1048-57. PubMed ID: 20035012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.